Alvaro
Hernandez Vicente
Hospital Virgen de la Arrixaca
Murcia, EspañaHospital Virgen de la Arrixaca -ko ikertzaileekin lankidetzan egindako argitalpenak (9)
2024
-
Withdrawal of drug therapy in responders to cardiac resynchronization therapy: rationale and design of the REMOVE trial
Revista Espanola de Cardiologia
2023
-
Value of increased soluble suppressor tumorigenicity biomarker 2 (sST2) on admission as an indicator of severity in patients with COVID-19
Medicina Clinica, Vol. 161, Núm. 5, pp. 185-191
2022
-
CA 15-3 prognostic biomarker in SARS-CoV-2 pneumonia
Scientific Reports, Vol. 12, Núm. 1
-
Critical warm ischemia time point for cardiac donation after circulatory death
American Journal of Transplantation, Vol. 22, Núm. 5, pp. 1321-1328
2021
-
Colchicine in recently hospitalized patients with COVID-19: A randomized controlled trial (COL-COVID)
International Journal of General Medicine, Vol. 14, pp. 5517-5526
2020
-
Impact of pre-hospital renal function on the detection of acute kidney injury in acute decompensated heart failure
European Journal of Internal Medicine, Vol. 77, pp. 66-72
2019
-
Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure
Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 315-319
-
Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 740-748
2018
-
Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population
International Journal of Cardiology, Vol. 270, pp. 192-196